I share evidence-based cancer news, research breakthroughs and survivor stories — no hype, no miracle cures. This feed is for patients, families, clinicians and anyone who believes progress matters. Follow for facts, hope & real science! Curated by @Chris_Geiger #TCSC

Cancer survivorship deserves celebrating! Springfield’s Rise Above Cancer Gala honoured people affected by cancer while raising funds for survivor guidance, peer support and practical resources. westernmassnews.com/2026/10/… #CancerSurvivor #CancerSupport #TCSC

Encouraging lung cancer news! A Phase 3 trial found divarasib extended median survival to 17.7 months versus 12 months with existing targeted treatments for KRAS G12C-mutated lung cancer. bioquicknews.com/esmo-2026-n… #LungCancer #CancerResearch #TCSC

Some genuinely encouraging cancer news! A new triple therapy has shrunk tumours in 77% of patients in a small trial involving aggressive head and neck cancer. Early days, but real hope for patients. medium.com/@asecondopinion/t… #CancerResearch #CancerTreatment #Immunotherapy #TCSC

Doctors recommended hospice care. But a clinical trial changed everything. Diagnosed with aggressive leukaemia, father-of-three Ryan Goepel entered remission within weeks and is now two years cancer-free. An extraordinary story! cbsnews.com/news/acute-myelo… #Leukaemia #Cancer #TCSC

Two remarkable women, two inspiring stories. Diagnosed with breast cancer while navigating motherhood and major life changes, Jenna Tomasiewicz and Margot Casino are now sharing their experiences to raise awareness and support others. cbsnews.com/newyork/news/bre… #BreastCancer #TCSC

Sometimes laughter really does help. Breast cancer survivors in Harlem are using stand-up comedy to share their experiences, raise awareness and support others facing a diagnosis. A wonderful example of turning pain into purpose. cbsnews.com/newyork/news/bre… #BreastCancer #TCSC

Encouraging news for lung cancer patients. ZEGFROVY, a once-daily targeted tablet, is now available in the US for certain patients with EGFR exon 20 mutations after chemotherapy. Trials showed a 46% tumour response rate. cancernetwork.com/view/sunvo… #LungCancer #Cancer #TCSC

The NHS Has Found a Miracle Weight-Loss Drug. Unfortunately, the Waiting List Is 12 Years Long... medium.com/@asecondopinion/t… #NHS #Column #WeightLoss #Mounjaro

A major step forward for personalised cancer vaccines. Phase 3 results show Moderna and Merck’s mRNA therapy, combined with Keytruda, reduced the risk of melanoma recurrence or death by 42% compared with Keytruda alone. reuters.com/legal/litigation… #Melanoma #CancerResearch #TCSC

Timing matters in multiple myeloma care. Specialists say earlier referral for CAR-T assessment could help eligible patients access treatment before their disease progresses further. cancernetwork.com/view/earli… #MultipleMyeloma #CARTCellTherapy #TCSC

Scientists are finding ways to make CAR-T cells stronger and longer-lasting. New research could improve future immunotherapy for cancers that spread to bone, including prostate cancer. moffitt.org/newsroom/news-re… #Immunotherapy #CancerResearch #TCSC

A major advance for rectal cancer. The FDA has approved Jemperli immunotherapy for certain stage II/III tumours, potentially allowing patients to avoid chemotherapy, radiation and surgery. fda.gov/drugs/resources-info… #RectalCancer #TCSC

Cancer research continues to accelerate. The AACR’s latest report highlights 11 new cancer therapies, advances in targeted drugs, blood-based tumour DNA testing and personalised vaccines. targetedonc.com/view/aacr-ca… #CancerResearch #Oncology #TCSC

Less time in hospital, more time living. Some cancer treatments once given through lengthy IV infusions can now be delivered as quicker injections, helping reduce the burden of treatment for eligible patients. targetedonc.com/shorts/the-s… #CancerTreatment #CancerCare #TCSC

Lung cancer treatment is becoming more personalised. A new review explores how genetic testing and targeted drugs are improving care, including treatments designed to reach brain metastases. nature.com/articles/s41392-0… #LungCancer #CancerResearch #TCSC

A new approach to pancreatic cancer uses combinations of RNA therapies to switch cancer-related genes on or off. Early laboratory research suggests treatment could be tailored to each tumour’s biology. advancedsciencenews.com/comb… #PancreaticCancer #TCSC

Promising news for small-cell lung cancer. An experimental targeted drug, Ris-Rez, shrank tumours in 61% of evaluable patients at the selected dose in an early trial. Larger studies are underway. gsk.com/en-gb/media/press-re… #LungCancer #TCSC

Let’s not forget the men. Breast cancer isn’t exclusively a women’s disease. Around 1% of all breast cancer cases occur in men, with approximately 20,000 men diagnosed worldwide each year. Awareness matters for everyone, particularly as many men don’t even realise they’re at risk

Promising results for complex kidney cancer. A Phase 2 trial combining targeted radiation with surgery found 71% of patients remained recurrence-free after one year. branding.utsouthwestern.edu/… #KidneyCancer #Radiotherapy #TCSC